ADVFN Logo
Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

KROS Keros Therapeutics Inc

57.48
-1.14 (-1.94%)
Last Updated: 15:22:12
Delayed by 15 minutes

Income Statement

Balance Sheet

Cash Flow

Quarter End Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023
USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)
Total Revenue 20M0000008k
Operating Income -4.87M-24.13M-30.73M-27.98M-31.96M-38.87M-41.34M-43.28M
Pre Tax Income -4.94M-24.19M-27.27M-23.51M-29.72M-35.8M-37.51M-39.44M
Net Income -6.94M-24.19M-27.27M-23.51M-29.72M-35.8M-37.51M-39.44M
Preferred Dividends 00000000
Basic Earnings Per Share (EPS) 00000000
EBIT -4.94M-24.19M-27.33M-23.51M-29.72M-35.8M-37.51M-39.44M
EBITDA -4.76M-24.01M-30.42M-27.85M-31.81M-38.7M-41.15M-43.07M
Year End December 30 2023 201820192020202120222023
USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)
Total Revenue 10M10M020.1M0151k
Operating Income -1.69M-10.56M-46.66M-56.37M-114.79M-169.94M
Pre Tax Income -1.08M-12.34M-45.53M-56.73M-104.68M-152.99M
Net Income -1.34M-12.34M-45.36M-58.74M-104.68M-152.99M
Preferred Dividends 000000
Basic Earnings Per Share (EPS) -0.595-5.077-1.956-2.45-3.801-5.107
EBIT -1.08M-12.33M-45.53M-56.73M-104.68M-167.75M
EBITDA -1.54M-10.36M-46.38M-56M-114.09M-169.13M

Your Recent History

Delayed Upgrade Clock